Diabetes and Cardiovascular Risk in Renal Transplant Patients
End-stage kidney disease (ESKD) is a main public health problem, the prevalence of which is continuously increasing worldwide. Due to adverse effects of renal replacement therapies, kidney transplantation seems to be the optimal form of therapy with significantly improved survival, quality of life a...
Main Authors: | Jacek Rysz, Beata Franczyk, Maciej Radek, Aleksandra Ciałkowska-Rysz, Anna Gluba-Brzózka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/7/3422 |
Similar Items
-
Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases
by: Jacek Rysz, et al.
Published: (2020-11-01) -
The Role of Metabolic Factors in Renal Cancers
by: Jacek Rysz, et al.
Published: (2020-09-01) -
The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk
by: Marek Femlak, et al.
Published: (2017-10-01) -
Is preimplantation renal biopsy essential prior to deceased donor renal transplant?
by: M Edwin Fernando, et al.
Published: (2019-01-01) -
Pediatric Renal Transplantation
by: B. Saeed
Published: (2012-04-01)